Mitoflaxone
Based on 1 Customer Validation
Mitoflaxone (flavoneacetic acid) is a synthetic flavonoid compound with vascular targeting properties. Mitoflaxone exerts anti-proliferative effects on endothelial cells through a superoxide-dependent mechanism, this effect leads to changes in the permeability of tumor blood vessels, thereby exerting anti-tumor effects[1][2].
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.82%
- CAS. Nr.: 87626-55-9
- Formel: C17H12O4
- Molecular Weight:280.27
-
Speicherung:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 2008 | IC50 |
421.3 μM
Compound: FAA (Flavone -8-acetic acid)
|
Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells
Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells
|
[PMID: 12904070] |
| A549 | IC50 |
341.5 μM
Compound: 2, FAA
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 24518295] |
| C13 | IC50 |
233.3 μM
Compound: FAA (Flavone -8-acetic acid)
|
Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells
Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells
|
[PMID: 12904070] |
| DLD-1 | IC50 |
>500 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit DLD1 cells
In vitro concentration required to inhibit DLD1 cells
|
10.1016/0960-894X(94)85031-3 |
| HCT-8 | IC50 |
245 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit HCT18 cells
In vitro concentration required to inhibit HCT18 cells
|
10.1016/0960-894X(94)85031-3 |
| HT-29 | IC50 |
2449.5 μM
Compound: 2, FAA
|
Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay
|
[PMID: 24518295] |
| HT-29 | IC50 |
390 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit HT-29 cells
In vitro concentration required to inhibit HT-29 cells
|
10.1016/0960-894X(94)85031-3 |
| K562 | IC50 |
310 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit K562 cells
In vitro concentration required to inhibit K562 cells
|
10.1016/0960-894X(94)85031-3 |
| LoVo | IC50 |
378.3 μM
Compound: FAA (Flavone -8-acetic acid)
|
In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined
In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined
|
[PMID: 12904070] |
| LoVo | IC50 |
563.9 μM
Compound: FAA (Flavone -8-acetic acid)
|
In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined
In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined
|
[PMID: 12904070] |
| MAC15A | IC50 |
150 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit MAC 15 A cells
In vitro concentration required to inhibit MAC 15 A cells
|
10.1016/0960-894X(94)85031-3 |
| MAC16 | IC50 |
180 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit MAC 16 cells
In vitro concentration required to inhibit MAC 16 cells
|
10.1016/0960-894X(94)85031-3 |
| MAC26 | IC50 |
208 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
|
In vitro concentration required to inhibit MAC 26 cells
In vitro concentration required to inhibit MAC 26 cells
|
10.1016/0960-894X(94)85031-3 |
Chemical Information
-
CAS. Nr. 87626-55-9
-
Appearance Solid
-
Molecular Weight 280.27
-
Formel C17H12O4
-
Color White to off-white
-
SMILES
O=C1C2=C(C(CC(O)=O)=CC=C2)OC(C3=CC=CC=C3)=C1
-
Synonyms
Flavoneacetic acid
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 70 mg/mL (249.76 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Protokoll
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Reinheit & Dokumentation
-
Data Sheet (270 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5680 mL | 17.8399 mL | 35.6799 mL | 89.1997 mL |
| 5 mM | 0.7136 mL | 3.5680 mL | 7.1360 mL | 17.8399 mL | |
| 10 mM | 0.3568 mL | 1.7840 mL | 3.5680 mL | 8.9200 mL | |
| 15 mM | 0.2379 mL | 1.1893 mL | 2.3787 mL | 5.9466 mL | |
| 20 mM | 0.1784 mL | 0.8920 mL | 1.7840 mL | 4.4600 mL | |
| 25 mM | 0.1427 mL | 0.7136 mL | 1.4272 mL | 3.5680 mL | |
| 30 mM | 0.1189 mL | 0.5947 mL | 1.1893 mL | 2.9733 mL | |
| 40 mM | 0.0892 mL | 0.4460 mL | 0.8920 mL | 2.2300 mL | |
| 50 mM | 0.0714 mL | 0.3568 mL | 0.7136 mL | 1.7840 mL | |
| 60 mM | 0.0595 mL | 0.2973 mL | 0.5947 mL | 1.4867 mL | |
| 80 mM | 0.0446 mL | 0.2230 mL | 0.4460 mL | 1.1150 mL | |
| 100 mM | 0.0357 mL | 0.1784 mL | 0.3568 mL | 0.8920 mL |